September is Gynecologic Cancer Awareness Month 🎗️
Gynecologic cancers, including ovarian, endometrial, cervical, vulvar, and vaginal cancers, affect hundreds of thousands of women worldwide each year. Accurate […]
Gynecologic cancers, including ovarian, endometrial, cervical, vulvar, and vaginal cancers, affect hundreds of thousands of women worldwide each year. Accurate […]
Ten years ago, Microsatellite Instability (MSI) testing was largely confined to specialized academic labs. Today, it’s at the center of […]
Microsatellite Instability is a genomic signature that occurs when a cell’s DNA mismatch repair (MMR) system stops working properly. 📌 […]
🎗️ World Lung Cancer Day — a moment to reflect, raise awareness, and push for earlier, smarter diagnostics. Lung cancer […]
From May 21–23, we showcased our flagship solution, MSIcare, an AI-powered genomic analysis platform designed to detect microsatellite instability (MSI) […]
https://www.msinsight.tech/wp-content/uploads/2025/05/BFMTV-Lyon-Video-Clip1.mp4 We’re thrilled to share that our CEO, Arnaud Cutivet, was recently featured on **BFM LYON** (BFMTV) (Ma Santé) as […]
MSInsight is proud to be a contributing partner in PREDI-LYNCH, a six-year, €13.6 million Horizon Europe-funded initiative led by Oslo […]
👏 Thrilled to share a tremendous achievement with our contribution to an article accepted in Annals of Oncology🔍 This publication emphasizes […]
🏆 Our partner from CRSA PARIS and our CTO Toky Ratovomanana have been honored with the prestigious Axel Kahn Award by the SFMPP – Société […]
🏅 Great News! Our CSO and co-founder, Alex Duval, has been awarded the 2023 Raymond Rosen Prize by the Fondation pour […]